Terazosin Capsule
Product Images NDC 50090-0657

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 50090-0657). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500900657)

Label Image (Lbl500900657)
This is a product label for FeRazosin, which contains 1MG of the medication. It comes in a package of 56 capsules.*
FDA Label Image

Terazosin Hydrochloride Chemical Structure (Terazosin Hydrochloride Capsules 1)

FDA Label Image

Figure 1 (Terazosin Hydrochloride Capsules 2)

FDA Label Image

Figure 2 (Terazosin Hydrochloride Capsules 3)

Figure 2 (Terazosin Hydrochloride Capsules 3)
This appears to be a chart or numerical data showing the mean change from baseline over time, with measurements taken at various monthly intervals (0, 1, 2, 3, 6, 9, 12, 15, 18, 21, 24, 27, and 30 months). Without further context, it is unclear what the values being measured are.*
FDA Label Image

Figure 3 (Terazosin Hydrochloride Capsules 4)

Figure 3 (Terazosin Hydrochloride Capsules 4)
This appears to be a graph or chart of some sort, displaying values on a baseline in units of "mLsec" over a period of 30 months. However, without further context or information, it is difficult to determine what the values represent or what the purpose of the graph is.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.